Medtronic 670G Insulin Pump and the Impact on Glycemic Control, Quality of Life, and Compliance

Status unconfirmed

Conditions studied: Type 1 Diabetes Mellitus

In brief

Analyze the Medtronic 670g pump on glycemic control

Key facts

Study ID

NCT04329871

Run by

Metabolic Research Institute, Inc.

People needed

100

Starts

2020-03-24

Expected to finish

2021-03-23

Last updated by the study team

2020-04-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• age 18 or older
• Documented History of Type 1 Diabetes Mellitus
• 3 months continuous use of the Medtronic 670g pump system
• given written informed consent

You may not qualify if…

• Less than 3 months use of the Medtronic 670g pump system
• Taking any other medication, other than the insulin used in the Medtronic 670g pump, to manage their diabetes
• having medical conditions or taking medications that would preclude subject involvement or affect the outcomes being measured, in the opinion of the Investigator

Where it is running

• Metabolic Research Institute — West Palm Beach, Florida, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.